September 2022 Opposite Effects of Src Family Kinases on YAP and ERK Activation in Pancreatic Cancer adenocarcinoma (PDAC) remains an aggressive disease that is expected to become the second cause of cancer -mediated knockdown of YES1 and transfection of epitogue-tagged YAP mutants in PANC-1 and MiaPaCa-2 cancer

Upregulated in Hepatocellular Carcinoma "Hepatocellular carcinoma (HCC) is at the forefront of the global cancer , with some members of the RGS family being associated with liver cancer as well. By using the Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) data, our analysis revealed (clear renal cell carcinoma: p < 0.001, lung adenocarcinoma: p = 0.004, mesothelioma: p = 0.039, ovarian Our analysis further supports the putative function of RGS proteins, particularly RGS20, in cancer."

October 2022 ADGRL3 genomic variation implicated in neurogenesis and ADHD links functional effects to and in linkage with ADHD in disparate populations from the world over, are predicted as pathogenic variants

However, the role of β2-AR in oral cancer is not well identified.

Biotechnology Inc. and Trevena Inc. could offer potential new weapons against omicron and future viral variants While vaccine-makers race to test their shots against the variant, the monoclonal antibody sotrovimab Sotrovimab is the first monoclonal antibody showing preclinical efficacy against all COVID-19 variants

of attention because of its involvement in various diseases, such as idiopathic pulmonary fibrosis, cancers

sensory #ionchannels to the group leader at the University of Utah investigating Class F #GPCRs in #cancer

, arrestins, and effectors, activate downstream pathways that often modulate hallmark mechanisms of cancer To test this possibility, we systematically aggregated somatic cancer mutations across class A GPCRs Individual cancer types were enriched for highly impactful, recurrent mutations at selected cognate positions The possibility that multiple different GPCRs could moonlight as drivers or enablers of a given cancer through mutations located at cognate positions across GPCR paralogs opens a window into cancer mechanisms

can influence transcriptional responses and contribute to physiological processes such as meiosis in ovarian For instance, aberrant endosomal signaling by GPCRs has been linked to disorders such as cancer, neurodegenerative Persistent cAMP Signaling by Internalized LH Receptors in Ovarian Follicles. GPCRomics: GPCR Expression in Cancer Cells and Tumors Identifies New, Potential Biomarkers and Therapeutic

#technology #lifescience #immunology #antibodies #medicine #cancer #innovation #gpcr #synabs #monoclonalantibodies

autistic-like behavior Acetate mitigates cardiac mitochondrial dysfunction in experimental model of polycystic ovarian

October 2022 "While the role of G-protein-coupled receptors (GPCR) in cancer is acknowledged, their underlying demonstrate identification of a pleckstrin-homology (PH)-binding motif within PAR4, critical for colon cancer EGFR/erbB is among the most prominent cancer targets. Overall, our studies are expected to allocate new targets for cancer therapy. Pc(4-4) may become a promising candidate for future therapeutic cancer treatment."

macrophages in a quantitative systems pharmacology model of immunotherapy in triple-negative breast cancer It has begun to play important roles in drug development for complex diseases such as cancer, including triple-negative breast cancer (TNBC). incorporated the dynamics of TAMs into our previously published QSP model to investigate their impact on cancer

Matthew Eddy, et al. for their investigation on Interaction Networks within Disease-Associated GαS Variants ADGRB1/BAI1) Generated from an Alternative Promoter in Intron 17 The adhesion-GPCR ADGRF5 fuels breast cancer in Oncology and Immunology Metabolic crosstalk: Extracellular ATP and the tumor microenvironment in cancer progression and therapy Agonists of galanin subtype 2 receptor may prevent pancreatic cancer and agonists of angiotensin II type 2 receptor may prevent colorectal cancer Distinct Activation Mechanisms of CXCR4

and infectious diseases (Proudfoot 2002), and in recent years attention has increasingly focused on cancer The involvement of chemokines and their receptors in several aspects of cancer biology, represents a inhibitor of the CCR5 used in HIV therapy; and the small molecule plerixafor, a CXCR4 antagonist used in cancer A lot of effort has been put forward to target CKRs especially in cancer, nevertheless, targeting this receptors redundancy and the fact that different chemokine receptors are overexpressed and promote cancer

adhesion G protein-coupled receptors as potential therapeutic targets in Uterine Corpus Endometrial cancer The structure, function, and involvement of adhesion GPCRs in cancer development have been discussed

Miles Thompson, Alexander Hauser, Caroline Gorvin et al. for their research on GPCR gene variants and colitis GPCRs in Oncology and Immunology Polarizing itch Biochemical pharmacology of adenylyl cyclases in cancer and human genetic disease Advances and challenges in cancer immunoprevention and immune interception serotonin, dopamine and norepinephrine transporters and their AlphaFold2 predicted water-soluble QTY variants Inflammatory Bowel Disease (IBD) Domain Therapeutics and Chime Biologics Form Manufacturing Pact for Antibody Cancer

expression data in healthy tissues from the Genotype-Tissue Expression (GTEx) database with data from cancer samples in The Cancer Genome Atlas (TCGA) through the Gene Expression Profiling Interactive Analysis (GEPIA) tool, it is evident that β-arrestin expression is dysregulated in many cancer types. In certain cancer types, only one β-arrestin isoform's expression may be altered, while the other remains downstream signaling complexes, contributing to the complex landscape of cancer-related signaling pathways

A unique melanocortin-4-receptor signaling profile for obesity-associated constitutively active variants Gi/o GPCRs drive the formation of actin-rich tunneling nanotubes in cancer cells via a Gβγ/PKCα/FARP1 Esophageal and gastric cancer incidence trends in Golestan, Iran: An age-period-cohort analysis 2004 Autocrine proteinase-activated receptor signaling in PC3 prostate cancer cells. Multi-omics integration analysis of GPCRs in pan-cancer to uncover inter-omics relationships and potential

in autism spectrum disorders GPCRs in Oncology and Immunology Molecular characterization of breast cancer 2023 Half Year And Second Quarter Financial Results And Provides Corporate Update Sosei Heptares and Cancer Research UK Announce the Dosing of the First Patient in a Phase I/IIa Trial with Cancer Immunotherapy

In various pathological conditions, including cancer, aberrant ERK activity can lead to uncontrolled ERK: a double-edged sword in cancer. ERK-dependent apoptosis as a potential therapeutic strategy for cancer. Cells, 10(10), 2509.

ubiquitously expressed ORs, although there are highly increased in prostate tissue, especially in prostate cancer modulated by this tight mechanism with transcriptomic analysis revealing that while the majority of cancer and OR51E2, initially assumed to be GPCRs only expressed in prostate tissue, play a role in prostate cancer epithelial cells proliferation via activation by β-ionone which initiates prostate cancer cell cycle In non-small-cell lung cancer OR2J3 activation induced apoptosis and inhibited cell proliferation and

focused on orally administered therapeutics to treat autoimmune diseases, inflammatory disorders and cancer

novel proteins for biology and health research Innovate UK announced the winners of its Transforming Cancer Therapeutics grant, which focuses on developing life-changing cancer treatments. power of many: Multilevel targeting of representative chemokine and metabolite GPCRs in personalized cancer

phosphorylation events highlights a nuanced regulatory mechanism that could be crucial in contexts such as cancer GPCR-dependent pathways by growth factor signaling might contribute to altered cellular behaviors in cancer

Small-molecule targeting of GPCR-independent noncanonical G-protein signaling in cancer. BRET-based assays allow the analysis of binding kinetics of WNT-3A to endogenous Frizzled 7 in a colorectal cancer Genetic variants of G-protein coupled receptors associated with pubertal disorders. RGS proteins and their roles in cancer: friend or foe?. discussion at the LSX World Congress Novel living yeast-based dual biosensor for detecting peptide variants

Dysfunction of B2R is also closely related to cancers and hereditary angioedema (HAE).

Adam W Smith for their research on β2-adrenergic receptor associates with CXCR4 multimers in human cancer GPCRs in Oncology and Immunology The β2-adrenergic receptor associates with CXCR4 multimers in human cancer Therapeutics Announces Publication in PNAS Using Cutting Edge Spectroscopy to Detect GPCR Heteromers on Live Cancer